These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7609554)

  • 21. Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease.
    Gazit AZ; Canter CE
    Curr Cardiol Rev; 2011 May; 7(2):59-66. PubMed ID: 22548028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome.
    Cacoub P; Dorent R; Maistre G; Nataf P; Carayon A; Piette C; Godeau P; Cabrol C; Gandjbakhch I
    Am J Cardiol; 1993 Feb; 71(5):448-50. PubMed ID: 8430638
    [No Abstract]   [Full Text] [Related]  

  • 24. [Stages of heart defects as a reflection of the compensation--para-compensation development].
    Meshalkin EN; Litasova EE; Vlasov IuA; Okuneva GN; Chasovskikh GG
    Vestn Akad Med Nauk SSSR; 1991; (7):50-4. PubMed ID: 1838225
    [No Abstract]   [Full Text] [Related]  

  • 25. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?
    Beghetti M; Galiè N; Bonnet D
    Congenit Heart Dis; 2012; 7(1):3-11. PubMed ID: 22233186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the pulmonary circulation.
    Linde LM; Simmons DH
    UCLA Forum Med Sci; 1970; 10():321-9. PubMed ID: 5521145
    [No Abstract]   [Full Text] [Related]  

  • 27. [Assessment of pulmonary hypertension in congenital heart defects in childhood].
    Beuren AJ
    Klin Padiatr; 1972 Jan; 184(1):1-3. PubMed ID: 5063475
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma endothelin 1 concentrations in children with congenital heart defects.
    Jia B; Zhang S; Chen Z; Li Z; Li X; Hui W; Ye M
    Minerva Pediatr; 1998 Apr; 50(4):99-103. PubMed ID: 9808961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease.
    Dai H; Gong Y; Xiao Z; Guang X; Yin X
    Int J Cardiol; 2014 Oct; 176(3):1399-401. PubMed ID: 25150487
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance.
    Viswanathan S; Kumar RK
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):665-70. PubMed ID: 18360864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The changes of plasma endothelin concentration and its clinical significance in pulmonary hypertension associated with congenital heart defects].
    Zhang S; Qi S; Shen X; Zhou S; Jin S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):425-7. PubMed ID: 10073026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary biopsy for evaluation of vascular disease secondary to congenital heart disease].
    Kalil RA; Coutinho L; Lucchese FA; Prates PR; Sant'Anna JR; Pereira E; Nesralla IA; Bertoletti VE; Cardoso CR
    Arq Bras Cardiol; 1983 Sep; 41(3):199-202. PubMed ID: 6675611
    [No Abstract]   [Full Text] [Related]  

  • 33. The pulmonary circulation in congenital heart disease. II. Pulmonary hypertension.
    Haworth SG
    Herz; 1978 Apr; 3(2):138-42. PubMed ID: 721042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cyclic 3',5'-adenosine monophosphate in patients with elevated pulmonary pressure due to left-to-right shunt.
    Loukanov T; Takahashi H; Tonchev P; Gross J; Bettendorf M; Gorenflo M
    Can J Cardiol; 2011; 27(4):523.e25-9. PubMed ID: 21652166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary hypertension in pediatric heart surgery].
    Falcone N
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):462-4. PubMed ID: 11792301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy.
    Dimopoulos K; Peset A; Gatzoulis MA
    Int J Cardiol; 2008 Sep; 129(2):163-71. PubMed ID: 18367267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary hypertension in congenital cardiopathies. Surgical considerations].
    Villagra F; Sánchez PA
    Rev Esp Cardiol; 1982; 35(6):489-92. PubMed ID: 7184083
    [No Abstract]   [Full Text] [Related]  

  • 38. Alveolar recruitment manoeuvre is safe in children prone to pulmonary hypertensive crises following open heart surgery: a pilot study.
    Amorim Ede F; Guimaraes VA; Carmona F; Carlotti AP; Manso PH; Ferreira CA; Klamt JG; Vicente WV
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):602-6. PubMed ID: 24480822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of mechanical ventilation and inhalation of pulmonary vasodilators, upon pulmonary blood flow and pulmonary vascular resistance.
    Kern H; Kox WJ
    Cardiol Young; 2000 Mar; 10(2):166-70. PubMed ID: 10817306
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pulmonary hypertension in the surgery of congenital heart defects].
    Burakovskiĭ VI; Fal'kovskiĭ GE; Plotnikova LR; Gordonova MI; Gorchakova AI
    Ter Arkh; 1983; 55(1):81-6. PubMed ID: 6836533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.